Compugen | CGEN - Sales Revenues


Compugen reported $1.89M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 190K 2.03M Sep/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Minerva Neurosciences USD 0 0 Sep/2024
RedHill Biopharma USD 1.29M 722K Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024